Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Acute myeloid leukemia 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Acute myeloid leukemia
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 2 | Adipocytokine signaling pathway 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Adipocytokine signaling pathway
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 3 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬AGE-RAGE signaling pathway in diabetic complications
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 4 | Alcoholic liver disease 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Alcoholic liver disease
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 5 | Alzheimer disease 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Alzheimer disease
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 6 | Amoebiasis 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Amoebiasis
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 7 | Apoptosis 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Apoptosis
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 8 | B cell receptor signaling pathway 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬B cell receptor signaling pathway
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 9 | C-type lectin receptor signaling pathway 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬C-type lectin receptor signaling pathway
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 10 | cAMP signaling pathway 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬cAMP signaling pathway
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 11 | Cellular senescence 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Cellular senescence
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 12 | Chagas disease 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Chagas disease
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 13 | Chemical carcinogenesis - reactive oxygen species 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Chemical carcinogenesis - reactive oxygen species
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 14 | Chemical carcinogenesis - receptor activation 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Chemical carcinogenesis - receptor activation
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 15 | Chemokine signaling pathway 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Chemokine signaling pathway
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 16 | Chronic myeloid leukemia 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Chronic myeloid leukemia
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 17 | Cocaine addiction 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Cocaine addiction
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 18 | Coronavirus disease - COVID-19 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Coronavirus disease - COVID-19
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 19 | Cytosolic DNA-sensing pathway 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Cytosolic DNA-sensing pathway
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 20 | Diabetic cardiomyopathy 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Diabetic cardiomyopathy
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 21 | Epithelial cell signaling in Helicobacter pylori infection 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Epithelial cell signaling in Helicobacter pylori infection
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 22 | Epstein-Barr virus infection 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Epstein-Barr virus infection
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 23 | Fluid shear stress and atherosclerosis 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Fluid shear stress and atherosclerosis
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 24 | Hepatitis B 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Hepatitis B
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 25 | Hepatitis C 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Hepatitis C
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 26 | Herpes simplex virus 1 infection 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Herpes simplex virus 1 infection
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 27 | HIF-1 signaling pathway 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬HIF-1 signaling pathway
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 28 | Human cytomegalovirus infection 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Human cytomegalovirus infection
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 29 | Human immunodeficiency virus 1 infection 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Human immunodeficiency virus 1 infection
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 30 | Human papillomavirus infection 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Human papillomavirus infection
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 31 | Human T-cell leukemia virus 1 infection 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Human T-cell leukemia virus 1 infection
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 32 | IL-17 signaling pathway 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬IL-17 signaling pathway
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 33 | Inflammatory bowel disease 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Inflammatory bowel disease
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 34 | Influenza A 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Influenza A
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 35 | Insulin resistance 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Insulin resistance
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 36 | Kaposi sarcoma-associated herpesvirus infection 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Kaposi sarcoma-associated herpesvirus infection
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 37 | Legionellosis 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Legionellosis
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 38 | Leishmaniasis 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Leishmaniasis
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 39 | Lipid and atherosclerosis 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Lipid and atherosclerosis
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 40 | Longevity regulating pathway 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Longevity regulating pathway
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 41 | MAPK signaling pathway 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬MAPK signaling pathway
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 42 | Measles 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Measles
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 43 | MicroRNAs in cancer 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬MicroRNAs in cancer
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 44 | Neurotrophin signaling pathway 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Neurotrophin signaling pathway
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 45 | Neutrophil extracellular trap formation 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Neutrophil extracellular trap formation
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 46 | NF-kappa B signaling pathway 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬NF-kappa B signaling pathway
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 47 | NOD-like receptor signaling pathway 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬NOD-like receptor signaling pathway
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 48 | Non-alcoholic fatty liver disease 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Non-alcoholic fatty liver disease
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 49 | Osteoclast differentiation 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Osteoclast differentiation
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 50 | Pancreatic cancer 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Pancreatic cancer
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 51 | Pathogenic Escherichia coli infection 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Pathogenic Escherichia coli infection
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 52 | Pathways in cancer 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Pathways in cancer
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 53 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Pathways of neurodegeneration - multiple diseases
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 54 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 55 | Pertussis 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Pertussis
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 56 | PI3K-Akt signaling pathway 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬PI3K-Akt signaling pathway
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 57 | Prolactin signaling pathway 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Prolactin signaling pathway
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 58 | Prostate cancer 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Prostate cancer
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 59 | Ras signaling pathway 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Ras signaling pathway
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 60 | Relaxin signaling pathway 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Relaxin signaling pathway
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 61 | RIG-I-like receptor signaling pathway 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬RIG-I-like receptor signaling pathway
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 62 | Salmonella infection 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Salmonella infection
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 63 | Shigellosis 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Shigellosis
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 64 | Small cell lung cancer 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Small cell lung cancer
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 65 | Sphingolipid signaling pathway 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Sphingolipid signaling pathway
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 66 | T cell receptor signaling pathway 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬T cell receptor signaling pathway
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 67 | Th1 and Th2 cell differentiation 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Th1 and Th2 cell differentiation
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 68 | Th17 cell differentiation 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Th17 cell differentiation
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 69 | TNF signaling pathway 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬TNF signaling pathway
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 70 | Toll-like receptor signaling pathway 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Toll-like receptor signaling pathway
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 71 | Toxoplasmosis 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Toxoplasmosis
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 72 | Transcriptional misregulation in cancer 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Transcriptional misregulation in cancer
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 73 | Tuberculosis 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Tuberculosis
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 74 | Viral carcinogenesis 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Viral carcinogenesis
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||
| 75 | Yersinia infection 💬 1 gene, 1 drug (DrugBank) and 6 diseases |
NFKB1 [1] NFKB1 💬Acute myeloid leukemia
|
Iguratimod Iguratimod 💬Yersinia infection
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬1. Acute myeloid leukemia
|
Acute myeloid leukemia
1 gene, 1 drug (DrugBank) and 6 diseases
Adipocytokine signaling pathway
1 gene, 1 drug (DrugBank) and 6 diseases
AGE-RAGE signaling pathway in diabetic complications
1 gene, 1 drug (DrugBank) and 6 diseases
Alcoholic liver disease
1 gene, 1 drug (DrugBank) and 6 diseases
Alzheimer disease
1 gene, 1 drug (DrugBank) and 6 diseases
Amoebiasis
1 gene, 1 drug (DrugBank) and 6 diseases
Apoptosis
1 gene, 1 drug (DrugBank) and 6 diseases
B cell receptor signaling pathway
1 gene, 1 drug (DrugBank) and 6 diseases
C-type lectin receptor signaling pathway
1 gene, 1 drug (DrugBank) and 6 diseases
cAMP signaling pathway
1 gene, 1 drug (DrugBank) and 6 diseases
Cellular senescence
1 gene, 1 drug (DrugBank) and 6 diseases
Chagas disease
1 gene, 1 drug (DrugBank) and 6 diseases
Chemical carcinogenesis - reactive oxygen species
1 gene, 1 drug (DrugBank) and 6 diseases
Chemical carcinogenesis - receptor activation
1 gene, 1 drug (DrugBank) and 6 diseases
Chemokine signaling pathway
1 gene, 1 drug (DrugBank) and 6 diseases
Chronic myeloid leukemia
1 gene, 1 drug (DrugBank) and 6 diseases
Cocaine addiction
1 gene, 1 drug (DrugBank) and 6 diseases
Coronavirus disease - COVID-19
1 gene, 1 drug (DrugBank) and 6 diseases
Cytosolic DNA-sensing pathway
1 gene, 1 drug (DrugBank) and 6 diseases
Diabetic cardiomyopathy
1 gene, 1 drug (DrugBank) and 6 diseases
Epithelial cell signaling in Helicobacter pylori infection
1 gene, 1 drug (DrugBank) and 6 diseases
Epstein-Barr virus infection
1 gene, 1 drug (DrugBank) and 6 diseases
Fluid shear stress and atherosclerosis
1 gene, 1 drug (DrugBank) and 6 diseases
Hepatitis B
1 gene, 1 drug (DrugBank) and 6 diseases
Hepatitis C
1 gene, 1 drug (DrugBank) and 6 diseases
Herpes simplex virus 1 infection
1 gene, 1 drug (DrugBank) and 6 diseases
HIF-1 signaling pathway
1 gene, 1 drug (DrugBank) and 6 diseases
Human cytomegalovirus infection
1 gene, 1 drug (DrugBank) and 6 diseases
Human immunodeficiency virus 1 infection
1 gene, 1 drug (DrugBank) and 6 diseases
Human papillomavirus infection
1 gene, 1 drug (DrugBank) and 6 diseases
Human T-cell leukemia virus 1 infection
1 gene, 1 drug (DrugBank) and 6 diseases
IL-17 signaling pathway
1 gene, 1 drug (DrugBank) and 6 diseases
Inflammatory bowel disease
1 gene, 1 drug (DrugBank) and 6 diseases
Influenza A
1 gene, 1 drug (DrugBank) and 6 diseases
Insulin resistance
1 gene, 1 drug (DrugBank) and 6 diseases
Kaposi sarcoma-associated herpesvirus infection
1 gene, 1 drug (DrugBank) and 6 diseases
Legionellosis
1 gene, 1 drug (DrugBank) and 6 diseases
Leishmaniasis
1 gene, 1 drug (DrugBank) and 6 diseases
Lipid and atherosclerosis
1 gene, 1 drug (DrugBank) and 6 diseases
Longevity regulating pathway
1 gene, 1 drug (DrugBank) and 6 diseases
MAPK signaling pathway
1 gene, 1 drug (DrugBank) and 6 diseases
Measles
1 gene, 1 drug (DrugBank) and 6 diseases
MicroRNAs in cancer
1 gene, 1 drug (DrugBank) and 6 diseases
Neurotrophin signaling pathway
1 gene, 1 drug (DrugBank) and 6 diseases
Neutrophil extracellular trap formation
1 gene, 1 drug (DrugBank) and 6 diseases
NF-kappa B signaling pathway
1 gene, 1 drug (DrugBank) and 6 diseases
NOD-like receptor signaling pathway
1 gene, 1 drug (DrugBank) and 6 diseases
Non-alcoholic fatty liver disease
1 gene, 1 drug (DrugBank) and 6 diseases
Osteoclast differentiation
1 gene, 1 drug (DrugBank) and 6 diseases
Pancreatic cancer
1 gene, 1 drug (DrugBank) and 6 diseases
Pathogenic Escherichia coli infection
1 gene, 1 drug (DrugBank) and 6 diseases
Pathways in cancer
1 gene, 1 drug (DrugBank) and 6 diseases
Pathways of neurodegeneration - multiple diseases
1 gene, 1 drug (DrugBank) and 6 diseases
PD-L1 expression and PD-1 checkpoint pathway in cancer
1 gene, 1 drug (DrugBank) and 6 diseases
Pertussis
1 gene, 1 drug (DrugBank) and 6 diseases
PI3K-Akt signaling pathway
1 gene, 1 drug (DrugBank) and 6 diseases
Prolactin signaling pathway
1 gene, 1 drug (DrugBank) and 6 diseases
Prostate cancer
1 gene, 1 drug (DrugBank) and 6 diseases
Ras signaling pathway
1 gene, 1 drug (DrugBank) and 6 diseases
Relaxin signaling pathway
1 gene, 1 drug (DrugBank) and 6 diseases
RIG-I-like receptor signaling pathway
1 gene, 1 drug (DrugBank) and 6 diseases
Salmonella infection
1 gene, 1 drug (DrugBank) and 6 diseases
Shigellosis
1 gene, 1 drug (DrugBank) and 6 diseases
Small cell lung cancer
1 gene, 1 drug (DrugBank) and 6 diseases
Sphingolipid signaling pathway
1 gene, 1 drug (DrugBank) and 6 diseases
T cell receptor signaling pathway
1 gene, 1 drug (DrugBank) and 6 diseases
Th1 and Th2 cell differentiation
1 gene, 1 drug (DrugBank) and 6 diseases
Th17 cell differentiation
1 gene, 1 drug (DrugBank) and 6 diseases
TNF signaling pathway
1 gene, 1 drug (DrugBank) and 6 diseases
Toll-like receptor signaling pathway
1 gene, 1 drug (DrugBank) and 6 diseases
Toxoplasmosis
1 gene, 1 drug (DrugBank) and 6 diseases
Transcriptional misregulation in cancer
1 gene, 1 drug (DrugBank) and 6 diseases
Tuberculosis
1 gene, 1 drug (DrugBank) and 6 diseases
Viral carcinogenesis
1 gene, 1 drug (DrugBank) and 6 diseases
Yersinia infection
1 gene, 1 drug (DrugBank) and 6 diseases
